Review of published 467 achondroplasia patients: clinical and mutational spectrum
Open Access
- 27 January 2024
- journal article
- review article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 19 (1) , 1-10
Abstract
Aim: Achondroplasia is the most common of the skeletal dysplasias that cause fatal and disabling growth and developmental disorders in children, and is caused by a mutation in the fibroblast growth factor receptor, type 3 gene(FGFR3). This study aims to analyse the clinical characteristics and gene mutations of ACH to accurately determine whether a patient has ACH and to raise public awareness of the disease. Methods: The database of Pubmed, Cochrane Library, Wanfang and CNKI were searched with terms of “Achondroplasias” or “Skeleton-Skin-Brain Syndrome” or “Skeleton Skin Brain Syndrome” or “ACH” and “Receptor, Fibroblast Growth Factor, Type 3” or “FGFR3”. Results: Finally, four hundred and sixty-seven patients with different FGFR3 mutations were enrolled. Of the 138 patients with available gender information, 55(55/138, 40%) were female and 83(83/138, 60%) were male. Among the patients with available family history, 47(47/385, 12%) had a family history and 338(338/385, 88%) patients were sporadic. The age of the patients ranged from newborn babies to 36 years old. The mean age of their fathers was 37 ± 7 years (range 31–53 years). Patients came from 12 countries and 2 continents, with the majority being Asian (383/432, 89%), followed by European (49/432, 11%). Short stature with shortened arms and legs was found in 112(112/112) patients, the abnormalities of macrocephaly in 94(94/112) patients, frontal bossing in 89(89/112) patients, genu valgum in 64(64/112) patients and trident hand were found in 51(51/112) patients. The most common mutation was p.Gly380Arg of the FGFR3 gene, which contained two different base changes, c.1138G > A and c.1138G > C. Ten rare pathogenic mutations were found, including c.831A > C, c.1031C > G, c.1043C > G, c.375G > T, c.1133A > G, c.1130T > G, c.833A > G, c.649A > T, c.1180A > T and c.970_971insTCTCCT. Conclusion: ACH was caused by FGFR3 gene mutation, and c.1138G > A was the most common mutation type. This study demonstrates the feasibility of molecular genetic testing for the early detection of ACH in adolescents with short stature, trident hand, frontal bossing, macrocephaly and genu valgum.Keywords
Funding Information
- Innovative Research Group Project of the National Natural Science Foundation of China (8217082)
This publication has 55 references indexed in Scilit:
- Achondroplasia with 47, xxy karyotype: a case report of the neonatal diagnosis of an extremely unusual associationBMC Pediatrics, 2012
- Achondroplasia with synostosis of multiple suturesAmerican Journal of Medical Genetics Part A, 2011
- Clinical and Molecular diagnosis of the skeletal dysplasias associated with mutations in the gene encoding Fibroblast Growth Factor Receptor 3 (FGFR3) in PortugalClinical Genetics, 2009
- Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiencyJournal of Medical Genetics, 2006
- Severe complications in a child with achondroplasia and two FGFR3 mutations on the same alleleAmerican Journal of Medical Genetics Part A, 2006
- Growth hormone treatment in 35 prepubertal children with achondroplasia: A five‐year dose‐response trialActa Paediatrica, 2005
- Mesomelic and rhizomelic short stature: The phenotype of combined Leri‐Weill dyschondrosteosis and achondroplasia or hypochondroplasiaAmerican Journal of Medical Genetics Part A, 2002
- Germline and somatic mosaicism in achondroplasia: Figure 1Journal of Medical Genetics, 2000
- Achondroplasia in Sweden caused by the G1 138A mutation in FGFR3Acta Paediatrica, 1996
- Predominance of the mutation at 1138 of the cDNA for the fibroblast growth factor receptor 3 in Japanese patients with achondroplasiaJournal of Human Genetics, 1995